doi: 10.1097/CCM.0000000000005976 [PubMed] 37938118 Long MT, Kruser JM, Quinonez SC
The Right Tools for Weight Loss: Where GLP-1s Lead For a patient whose primary goal is weight loss, the clinical conversation starts with GLP-1 receptor agonists
n = 51) or only PT (Group 2
At our clinic, patients who come in with chronic GI inflammation, SIBO residuals, or a history of NSAID-induced gastritis are the group most likely to report subjective improvement on BPC-157 within the first 30 days
Direct comparison: the numbers side by side The raw percentage difference is approximately 8 percentage points in favor of retatrutide
As a topical cosmetic ingredient (copper tripeptide-1), it is widely available without prescription and has a strong tolerability record in that use